Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 347

1.

Pancreatic Cancer: From Genome Discovery to PRECISION-Panc.

Dreyer SB, Jamieson NB, Morton JP, Sansom OJ, Biankin AV, Chang DK.

Clin Oncol (R Coll Radiol). 2019 Sep 12. pii: S0936-6555(19)30343-7. doi: 10.1016/j.clon.2019.08.007. [Epub ahead of print] No abstract available.

PMID:
31522943
2.

Developing a Standardization Algorithm for Categorical Laboratory Tests for Clinical Big Data Research: Retrospective Study.

Kim M, Shin SY, Kang M, Yi BK, Chang DK.

JMIR Med Inform. 2019 Aug 29;7(3):e14083. doi: 10.2196/14083.

3.

Effectiveness of acid suppressants and other mucoprotective agents in reducing the risk of occult gastrointestinal bleeding in nonsteroidal anti-inflammatory drug users.

Kim TJ, Kim ER, Hong SN, Kim YH, Lee YC, Kim HS, Kim K, Chang DK.

Sci Rep. 2019 Aug 12;9(1):11696. doi: 10.1038/s41598-019-48173-6.

4.

Advances in Fetal Surgery: Current and Future Relevance in Plastic Surgery.

Gimenez A, Kopkin R, Chang DK, Belfort M, Reece EM.

Semin Plast Surg. 2019 Aug;33(3):204-212. doi: 10.1055/s-0039-1693431. Epub 2019 Aug 2. Review.

PMID:
31384237
5.

Bone Grafts, Bone Substitutes, and Orthobiologics: Applications in Plastic Surgery.

Raghuram A, Singh A, Chang DK, Nunez M, Reece EM.

Semin Plast Surg. 2019 Aug;33(3):190-199. doi: 10.1055/s-0039-1693020. Epub 2019 Aug 2. Review.

PMID:
31384235
6.

The Basics of Integra Dermal Regeneration Template and its Expanding Clinical Applications.

Chang DK, Louis MR, Gimenez A, Reece EM.

Semin Plast Surg. 2019 Aug;33(3):185-189. doi: 10.1055/s-0039-1693401. Epub 2019 Aug 2. Review.

PMID:
31384234
7.

The Evolving Landscape of Gene Therapy in Plastic Surgery.

Raghuram A, Singh A, Chang DK, Nunez M, Reece EM, Schultz BE.

Semin Plast Surg. 2019 Aug;33(3):167-172. doi: 10.1055/s-0039-1693131. Epub 2019 Aug 2. Review.

PMID:
31384232
8.

PRECISION-Panc: the Next Generation Therapeutic Development Platform for Pancreatic Cancer.

Dreyer SB, Jamieson NB, Cooke SL, Valle JW, McKay CJ, Biankin AV, Chang DK.

Clin Oncol (R Coll Radiol). 2019 Aug 2. pii: S0936-6555(19)30291-2. doi: 10.1016/j.clon.2019.07.011. [Epub ahead of print] No abstract available.

PMID:
31378449
9.

C-Reactive protein reduction rate following initiation of anti-tumor necrosis factor α induction therapy predicts secondary loss of response in patients with Crohn's disease.

Song JH, Hong SN, Lee JE, Kim K, Kim TJ, Kim ER, Chang DK, Kim YH.

Scand J Gastroenterol. 2019 Jul;54(7):876-885. doi: 10.1080/00365521.2019.1638962. Epub 2019 Jul 15.

PMID:
31303093
10.

CD1d Modulates Colonic Inflammation in NOD2-/- Mice by Altering the Intestinal Microbial Composition Comprising Acetatifactor muris.

Lee C, Hong SN, Paik NY, Kim TJ, Kim ER, Chang DK, Kim YH.

J Crohns Colitis. 2019 Aug 14;13(8):1081-1091. doi: 10.1093/ecco-jcc/jjz025.

PMID:
31094420
11.

Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling.

Dreyer SB, Jamieson NB, Evers L, Duthie F, Cooke S, Marshall J, Beraldi D, Knight S, Upstill-Goddard R, Dickson EJ, Carter CR, McKay CJ, Biankin AV, Chang DK.

Chin Clin Oncol. 2019 Apr;8(2):16. doi: 10.21037/cco.2019.04.06.

12.

Management of Complications of Colorectal Submucosal Dissection.

Kim ER, Chang DK.

Clin Endosc. 2019 Mar;52(2):114-119. doi: 10.5946/ce.2019.063. Epub 2019 Mar 29.

13.

A Mobile Phone-Based Self-Monitoring Tool for Perioperative Gastric Cancer Patients With Incentive Spirometer: Randomized Controlled Trial.

Soh JY, Lee SU, Lee I, Yoon KS, Song C, Kim NH, Sohn TS, Bae JM, Chang DK, Cha WC.

JMIR Mhealth Uhealth. 2019 Feb 19;7(2):e12204. doi: 10.2196/12204.

14.

Molecular subtypes of pancreatic cancer.

Collisson EA, Bailey P, Chang DK, Biankin AV.

Nat Rev Gastroenterol Hepatol. 2019 Apr;16(4):207-220. doi: 10.1038/s41575-019-0109-y. Review.

PMID:
30718832
15.

Variability in Doctors' Usage Paths of Mobile Electronic Health Records Across Specialties: Comprehensive Analysis of Log Data.

Soh JY, Jung SH, Cha WC, Kang M, Chang DK, Jung J, Lee J, Choi JS, Kim K.

JMIR Mhealth Uhealth. 2019 Jan 17;7(1):e12041. doi: 10.2196/12041.

16.

Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer.

Dreyer SB, Pinese M, Jamieson NB, Scarlett CJ, Colvin EK, Pajic M, Johns AL, Humphris JL, Wu J, Cowley MJ, Chou A, Nagrial AM, Chantrill L, Chin VT, Jones MD, Moran-Jones K, Carter CR, Dickson EJ, Samra JS, Merrett ND, Gill AJ, Kench JG, Duthie F, Miller DK, Cooke S, Aust D, Knösel T, Rümmele P, Grützmann R, Pilarsky C, Nguyen NQ, Musgrove EA, Bailey PJ, McKay CJ, Biankin AV, Chang DK; Australian Pancreatic Cancer Genome Initiative; Glasgow Precision Oncology Laboratory.

Ann Surg. 2018 Nov 30. doi: 10.1097/SLA.0000000000003143. [Epub ahead of print]

PMID:
30570546
17.

Comorbid immune-mediated diseases in inflammatory bowel disease: a nation-wide population-based study.

Park SW, Kim TJ, Lee JY, Kim ER, Hong SN, Chang DK, Yang M, Kim S, Shin MH, Kim YH.

Aliment Pharmacol Ther. 2019 Jan;49(2):165-172. doi: 10.1111/apt.15076. Epub 2018 Dec 2.

PMID:
30506945
18.

Experience of Emergency Department Patients With Using the Talking Pole Device: Prospective Interventional Descriptive Study.

Yoo J, Soh JY, Lee WH, Chang DK, Lee SU, Cha WC.

JMIR Mhealth Uhealth. 2018 Nov 22;6(11):e191. doi: 10.2196/mhealth.9676.

19.

ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy.

Veenstra VL, Damhofer H, Waasdorp C, van Rijssen LB, van de Vijver MJ, Dijk F, Wilmink HW, Besselink MG, Busch OR, Chang DK, Bailey PJ, Biankin AV, Kocher HM, Medema JP, Li JS, Jiang R, Pierce DW, van Laarhoven HWM, Bijlsma MF.

Oncogenesis. 2018 Nov 16;7(11):87. doi: 10.1038/s41389-018-0096-9.

20.
21.

The Effectiveness of Near-Field Communication Integrated with a Mobile Electronic Medical Record System: Emergency Department Simulation Study.

Jung KY, Kim T, Jung J, Lee J, Choi JS, Mira K, Chang DK, Cha WC.

JMIR Mhealth Uhealth. 2018 Sep 21;6(9):e11187. doi: 10.2196/11187.

22.

How to Detect Sessile Serrated Adenoma/Polyps.

Kim ER, Chang DK.

Clin Endosc. 2018 Jul;51(4):313-314. doi: 10.5946/ce.2018.108. Epub 2018 Jul 31. No abstract available.

23.

Risk of Metachronous Advanced Neoplasia in Patients With Multiple Diminutive Adenomas.

Kim JY, Kim TJ, Baek SY, Ahn S, Kim ER, Hong SN, Chang DK, Kim YH.

Am J Gastroenterol. 2018 Dec;113(12):1855-1861. doi: 10.1038/s41395-018-0210-9. Epub 2018 Aug 3.

PMID:
30072776
24.

Impact of sarcopenia on the risk of advanced colorectal neoplasia.

Hong JT, Kim TJ, Pyo JH, Kim ER, Hong SN, Kim YH, Ahn HS, Sohn I, Chang DK.

J Gastroenterol Hepatol. 2019 Jan;34(1):162-168. doi: 10.1111/jgh.14309. Epub 2018 Jun 25.

PMID:
29877584
25.

Development and Validation of a Multidisciplinary Mobile Care System for Patients With Advanced Gastrointestinal Cancer: Interventional Observation Study.

Soh JY, Cha WC, Chang DK, Hwang JH, Kim K, Rha M, Kwon H.

JMIR Mhealth Uhealth. 2018 May 7;6(5):e115. doi: 10.2196/mhealth.9363.

26.

Age and gender may be the key points in hyperglycemic patients with Helicobacter pylori infection combined colorectal adenoma-author's reply.

Kim TJ, Kim ER, Chang DK, Kim YH, Hong SN.

Helicobacter. 2018 Jun;23(3):e12484. doi: 10.1111/hel.12484. Epub 2018 Apr 11. No abstract available.

PMID:
29644785
27.

Efficacy of Mobile Health Care Application and Wearable Device in Improvement of Physical Performance in Colorectal Cancer Patients Undergoing Chemotherapy.

Cheong IY, An SY, Cha WC, Rha MY, Kim ST, Chang DK, Hwang JH.

Clin Colorectal Cancer. 2018 Jun;17(2):e353-e362. doi: 10.1016/j.clcc.2018.02.002. Epub 2018 Feb 17.

PMID:
29551558
28.

Defining the molecular pathology of pancreatic body and tail adenocarcinoma.

Dreyer SB, Jamieson NB, Upstill-Goddard R, Bailey PJ, McKay CJ; Australian Pancreatic Cancer Genome Initiative, Biankin AV, Chang DK.

Br J Surg. 2018 Jan;105(2):e183-e191. doi: 10.1002/bjs.10772.

30.

Measurements of 6-thioguanine nucleotide levels with TPMT and NUDT15 genotyping in patients with Crohn's disease.

Lee JH, Kim TJ, Kim ER, Hong SN, Chang DK, Choi LH, Woo HI, Lee SY, Kim YH.

PLoS One. 2017 Dec 5;12(12):e0188925. doi: 10.1371/journal.pone.0188925. eCollection 2017.

31.

Identification of risk factors for sessile and traditional serrated adenomas of the colon by using big data analysis.

Pyo JH, Ha SY, Hong SN, Chang DK, Son HJ, Kim KM, Kim H, Kim K, Kim JE, Choi YH, Kim YH.

J Gastroenterol Hepatol. 2018 May;33(5):1039-1046. doi: 10.1111/jgh.14035. Epub 2018 Feb 14.

PMID:
29087626
32.

Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer.

Chou A, Froio D, Nagrial AM, Parkin A, Murphy KJ, Chin VT, Wohl D, Steinmann A, Stark R, Drury A, Walters SN, Vennin C, Burgess A, Pinese M, Chantrill LA, Cowley MJ, Molloy TJ; Australian Pancreatic Cancer Genome Initiative (APGI), Waddell N, Johns A, Grimmond SM, Chang DK, Biankin AV, Sansom OJ, Morton JP, Grey ST, Cox TR, Turchini J, Samra J, Clarke SJ, Timpson P, Gill AJ, Pajic M.

Gut. 2018 Dec;67(12):2142-2155. doi: 10.1136/gutjnl-2017-315144. Epub 2017 Oct 28.

33.

Adenoma detection rate influences the risk of metachronous advanced colorectal neoplasia in low-risk patients.

Kim TJ, Kim ER, Hong SN, Kim YH, Baek SY, Ahn S, Chang DK.

Gastrointest Endosc. 2018 Mar;87(3):809-817.e1. doi: 10.1016/j.gie.2017.09.028. Epub 2017 Oct 4.

PMID:
28987544
34.

Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours.

Scarpa A, Chang DK, Nones K, Corbo V, Patch AM, Bailey P, Lawlor RT, Johns AL, Miller DK, Mafficini A, Rusev B, Scardoni M, Antonello D, Barbi S, Sikora KO, Cingarlini S, Vicentini C, McKay S, Quinn MCJ, Bruxner TJC, Christ AN, Harliwong I, Idrisoglu S, McLean S, Nourse C, Nourbakhsh E, Wilson PJ, Anderson MJ, Fink JL, Newell F, Waddell N, Holmes O, Kazakoff SH, Leonard C, Wood S, Xu Q, Hiriyur Nagaraj S, Amato E, Dalai I, Bersani S, Cataldo I, Dei Tos AP, Capelli P, Vittoria Davì M, Landoni L, Malpaga A, Miotto M, Whitehall VLJ, Leggett BA, Harris JL, Harris J, Jones MD, Humphris J, Chantrill LA, Chin V, Nagrial AM, Pajic M, Scarlett CJ, Pinho A, Rooman I, Toon C, Wu J, Pinese M, Cowley M, Barbour A, Mawson A, Humphrey ES, Colvin EK, Chou A, Lovell JA, Jamieson NB, Duthie F, Gingras MC, Fisher WE, Dagg RA, Lau LMS, Lee M, Pickett HA, Reddel RR, Samra JS, Kench JG, Merrett ND, Epari K, Nguyen NQ, Zeps N, Falconi M, Simbolo M, Butturini G, Van Buren G, Partelli S, Fassan M; Australian Pancreatic Cancer Genome Initiative, Khanna KK, Gill AJ, Wheeler DA, Gibbs RA, Musgrove EA, Bassi C, Tortora G, Pederzoli P, Pearson JV, Waddell N, Biankin AV, Grimmond SM.

Nature. 2017 Oct 26;550(7677):548. doi: 10.1038/nature24026. Epub 2017 Sep 27.

PMID:
28953865
35.

Interrogating open issues in cancer medicine with patient-derived xenografts.

Byrne AT, Alférez DG, Amant F, Annibali D, Arribas J, Biankin AV, Bruna A, Budinská E, Caldas C, Chang DK, Clarke RB, Clevers H, Coukos G, Dangles-Marie V, Eckhardt SG, Gonzalez-Suarez E, Hermans E, Hidalgo M, Jarzabek MA, de Jong S, Jonkers J, Kemper K, Lanfrancone L, Mælandsmo GM, Marangoni E, Marine JC, Medico E, Norum JH, Palmer HG, Peeper DS, Pelicci PG, Piris-Gimenez A, Roman-Roman S, Rueda OM, Seoane J, Serra V, Soucek L, Vanhecke D, Villanueva A, Vinolo E, Bertotti A, Trusolino L.

Nat Rev Cancer. 2017 Sep 15;17(10):632. doi: 10.1038/nrc.2017.85. [Epub ahead of print]

PMID:
28912576
36.

A prediction model for advanced colorectal neoplasia in an asymptomatic screening population.

Hong SN, Son HJ, Choi SK, Chang DK, Kim YH, Jung SH, Rhee PL.

PLoS One. 2017 Aug 25;12(8):e0181040. doi: 10.1371/journal.pone.0181040. eCollection 2017.

37.

Metabolic unhealthiness is an important predictor for the development of advanced colorectal neoplasia.

Kim TJ, Kim ER, Hong SN, Kim YH, Chang DK, Ji J, Kim JE, Kim HS, Kim K, Son HJ.

Sci Rep. 2017 Aug 21;7(1):9011. doi: 10.1038/s41598-017-08964-1.

39.

Clinical characteristics of patients with serrated polyposis syndrome in Korea: comparison with Western patients.

Kim ER, Jeon J, Lee JH, Lee YJ, Hong SN, Chang DK, Kim YH.

Intest Res. 2017 Jul;15(3):402-410. doi: 10.5217/ir.2017.15.3.402. Epub 2017 Jun 12.

40.

Current practices in endoscopic submucosal dissection for colorectal neoplasms: a survey of indications among Korean endoscopists.

Kim TJ, Kim ER, Hong SN, Kim YH, Chang DK.

Intest Res. 2017 Apr;15(2):228-235. doi: 10.5217/ir.2017.15.2.228. Epub 2017 Apr 27.

41.

Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma.

Feigin ME, Garvin T, Bailey P, Waddell N, Chang DK, Kelley DR, Shuai S, Gallinger S, McPherson JD, Grimmond SM, Khurana E, Stein LD, Biankin AV, Schatz MC, Tuveson DA.

Nat Genet. 2017 Jun;49(6):825-833. doi: 10.1038/ng.3861. Epub 2017 May 8.

42.

Lost in translation: returning germline genetic results in genome-scale cancer research.

Johns AL, McKay SH, Humphris JL, Pinese M, Chantrill LA, Mead RS, Tucker K, Andrews L, Goodwin A, Leonard C, High HA, Nones K, Patch AM, Merrett ND, Pavlakis N, Kassahn KS, Samra JS, Miller DK, Chang DK, Pajic M; Australian Pancreatic Cancer Genome Initiative, Pearson JV, Grimmond SM, Waddell N, Zeps N, Gill AJ, Biankin AV.

Genome Med. 2017 Apr 28;9(1):41. doi: 10.1186/s13073-017-0430-4.

44.

Pancreatic Cancer Genomes: Implications for Clinical Management and Therapeutic Development.

Dreyer SB, Chang DK, Bailey P, Biankin AV.

Clin Cancer Res. 2017 Apr 1;23(7):1638-1646. doi: 10.1158/1078-0432.CCR-16-2411. Review.

45.

BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer.

Pishvaian MJ, Biankin AV, Bailey P, Chang DK, Laheru D, Wolfgang CL, Brody JR.

Br J Cancer. 2017 Apr 11;116(8):1021-1026. doi: 10.1038/bjc.2017.40. Epub 2017 Mar 14.

46.

An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer.

Vallejo A, Perurena N, Guruceaga E, Mazur PK, Martinez-Canarias S, Zandueta C, Valencia K, Arricibita A, Gwinn D, Sayles LC, Chuang CH, Guembe L, Bailey P, Chang DK, Biankin A, Ponz-Sarvise M, Andersen JB, Khatri P, Bozec A, Sweet-Cordero EA, Sage J, Lecanda F, Vicent S.

Nat Commun. 2017 Feb 21;8:14294. doi: 10.1038/ncomms14294.

47.

Whole-genome landscape of pancreatic neuroendocrine tumours.

Scarpa A, Chang DK, Nones K, Corbo V, Patch AM, Bailey P, Lawlor RT, Johns AL, Miller DK, Mafficini A, Rusev B, Scardoni M, Antonello D, Barbi S, Sikora KO, Cingarlini S, Vicentini C, McKay S, Quinn MC, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, McLean S, Nourse C, Nourbakhsh E, Wilson PJ, Anderson MJ, Fink JL, Newell F, Waddell N, Holmes O, Kazakoff SH, Leonard C, Wood S, Xu Q, Nagaraj SH, Amato E, Dalai I, Bersani S, Cataldo I, Dei Tos AP, Capelli P, Davì MV, Landoni L, Malpaga A, Miotto M, Whitehall VL, Leggett BA, Harris JL, Harris J, Jones MD, Humphris J, Chantrill LA, Chin V, Nagrial AM, Pajic M, Scarlett CJ, Pinho A, Rooman I, Toon C, Wu J, Pinese M, Cowley M, Barbour A, Mawson A, Humphrey ES, Colvin EK, Chou A, Lovell JA, Jamieson NB, Duthie F, Gingras MC, Fisher WE, Dagg RA, Lau LM, Lee M, Pickett HA, Reddel RR, Samra JS, Kench JG, Merrett ND, Epari K, Nguyen NQ, Zeps N, Falconi M, Simbolo M, Butturini G, Van Buren G, Partelli S, Fassan M; Australian Pancreatic Cancer Genome Initiative, Khanna KK, Gill AJ, Wheeler DA, Gibbs RA, Musgrove EA, Bassi C, Tortora G, Pederzoli P, Pearson JV, Waddell N, Biankin AV, Grimmond SM.

Nature. 2017 Mar 2;543(7643):65-71. doi: 10.1038/nature21063. Epub 2017 Feb 15. Erratum in: Nature. 2017 Sep 27;:.

PMID:
28199314
48.

Obesity-related parameters and colorectal adenoma development.

Kim TJ, Kim JE, Choi YH, Hong SN, Kim YH, Chang DK, Rhee PL, Kim MJ, Jung SH, Son HJ.

J Gastroenterol. 2017 Dec;52(12):1221-1229. doi: 10.1007/s00535-017-1319-0. Epub 2017 Feb 14.

PMID:
28197803
49.

Helicobacter pylori infection is an independent risk factor of early and advanced colorectal neoplasm.

Kim TJ, Kim ER, Chang DK, Kim YH, Baek SY, Kim K, Hong SN.

Helicobacter. 2017 Jun;22(3). doi: 10.1111/hel.12377. Epub 2017 Jan 26.

PMID:
28124492
50.

Interrogating open issues in cancer precision medicine with patient-derived xenografts.

Byrne AT, Alférez DG, Amant F, Annibali D, Arribas J, Biankin AV, Bruna A, Budinská E, Caldas C, Chang DK, Clarke RB, Clevers H, Coukos G, Dangles-Marie V, Eckhardt SG, Gonzalez-Suarez E, Hermans E, Hidalgo M, Jarzabek MA, de Jong S, Jonkers J, Kemper K, Lanfrancone L, Mælandsmo GM, Marangoni E, Marine JC, Medico E, Norum JH, Palmer HG, Peeper DS, Pelicci PG, Piris-Gimenez A, Roman-Roman S, Rueda OM, Seoane J, Serra V, Soucek L, Vanhecke D, Villanueva A, Vinolo E, Bertotti A, Trusolino L.

Nat Rev Cancer. 2017 Apr;17(4):254-268. doi: 10.1038/nrc.2016.140. Epub 2017 Jan 20. Review. Erratum in: Nat Rev Cancer. 2017 Sep 15;:.

Supplemental Content

Loading ...
Support Center